Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06540820
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY
Sponsor:
None
Organization:
None
Study Overview
Official Title:
NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the effect of neuroendocrine dysfunctions on bone health in obesity
Detailed Description:
It is a multicentric observational cross-sectional non-profit study with additional procedures The study will include obese patients BMI30 with and without hyper functioning pituitary adenomas acromegaly Cushing and prolactinoma and hypopituitarism GH deficiency secondary hypogonadism aimed at studying the effect of metabolic phenotypes of obesity and neuroendocrine dysfunctions on bone health
Patients enrollment will take place in Ospedale San Raffaele Azienda Ospedaliera Universitaria Federico II di Napoli and UOC Endocrinologia-AOU Renato Dulbecco Università degli Studi di Catanzaro Magna Graecia
Patients enrollment will take place in Ospedale San Raffaele Azienda Ospedaliera Universitaria Federico II di Napoli and UOC Endocrinologia-AOU Renato Dulbecco Università degli Studi di Catanzaro Magna Graecia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None